Search

Emerging Treatments in Acute Lymphoblastic Leukemia

Journal: Current Cancer Drug Targets
Volume: 9 Issue: 1 Year: 2009 Page: 19-31
Author(s): R. Crazzolara, L. Bendall

The Prognosis and Treatment of Adult Acute Leukemia with 11q23/MLL According to the Fusion Partner

Journal: Current Cancer Therapy Reviews
Volume: 5 Issue: 3 Year: 2009 Page: 227-231
Author(s): Hayato Tamai, Hiroki Yamaguchi, Koiti Inokuchi, Kazuo Dan

Nilotinib Therapy in Chronic Myelogenous Leukemia: The Strength of High Selectivity on BCR/ABL

Journal: Current Drug Targets
Volume: 10 Issue: 6 Year: 2009 Page: 530-536
Author(s): Massimo Breccia, Giuliana Alimena

Tyrosine Kinase Inhibitors for the Treatment of Chronic Myeloid Leukemia

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 9 Issue: 8 Year: 2009 Page: 853-863
Author(s): Manlio Tolomeo, Francesco Dieli, Nicola Gebbia, Daniele Simoni

Life and Death of Leukemic Cells Under Bcr-Abl Signaling Control

Journal: Current Cancer Therapy Reviews
Volume: 5 Issue: 4 Year: 2009 Page: 303-309
Author(s): Junya Kuroda, Masafumi Taniwaki

Novel Drugs for Chronic Lymphoid Leukemias: Mechanism of Action and Therapeutic Activity

Journal: Current Medicinal Chemistry
Volume: 16 Issue: 1 Year: 2009 Page: 2212-2234
Author(s): Tadeusz Robak

Antiproliferative and Proapoptotic Effects of Proteasome Inhibitors and their Combination with Histone Deacetylase Inhibitors on Leukemia Cells

Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 9 Issue: 1 Year: 2009 Page: 62-77
Author(s): Ota Fuchs, Dana Provaznikova, Iuri Marinov, Katerina Kuzelova, Ivan Spicka

Discovery of 8-methoxypyrazino[1,2-a]indole as a New Potent Antiproliferative Agent Against Human Leukemia K562 Cells. A Structure-Activity Relationship Study

Journal: Letters in Drug Design & Discovery
Volume: 6 Issue: 4 Year: 2009 Page: 298-303
Author(s): Romeo Romagnoli, Pier Giovanni Baraldi, Maria Dora Carrion, Olga Cruz-Lopez, Carlota Lopez Cara, Delia Preti, Mojgan Aghazadeh Tabrizi, Jan Balzarini, Ernest Hamel, Enrica Fabbri, Roberto Gambari

The Combination of Conventional Chemotherapy with New Targeted Therapy in Hematologic Malignancies: The Safety and Efficiency of Low- Dose Cytarabine Supports its Combination with New Therapeutic Agents in Early Clinical Trials

Journal: Current Cancer Therapy Reviews
Volume: 5 Issue: 4 Year: 2009 Page: 243-255
Author(s): Hanne Fredly, Elisabeth Ersvaer, Camilla Stapnes, Bjorn Tore Gjertsen, Oystein Bruserud

Journal: Current Cancer Drug Targets
Volume: 9 Issue: 6 Year: 2009 Page: 761-776
Author(s):